July 9, 2020 / 3:37 PM / a month ago

BRIEF-Bioinvent to launch SEK 139 mln repair rights issue

July 9 (Reuters) - BioInvent International AB:

* BIOINVENT’S BOARD OF DIRECTORS RESOLVE ON A REPAIR RIGHTS ISSUE OF A MAXIMUM OF APPROX. SEK 139 MILLION, FOLLOWING THE SUCCESSFULLY COMPLETED DIRECTED SHARE ISSUE OF APPROX. SEK 487 MILLION

* BIOINVENT SAYS SUBSCRIPTION PRICE IN RIGHTS ISSUE WILL BE SEK 1.38 PER SHARE, WHICH IS SAME AS PRICE PER SHARE PAID IN DIRECTED SHARE ISSUE

* BIOINVENT SAYS PROVIDED THAT RIGHTS ISSUE IS FULLY SUBSCRIBED A MAXIMUM NUMBER OF 100,527,062 SHARES WILL BE ISSUED AND COMPANY WILL RECEIVE APPROXIMATELY SEK 139 MILLION BEFORE TRANSACTION COSTS.

* BIOINVENT SAYS NET PROCEEDS FROM RIGHTS ISSUE ARE MAINLY INTENDED FOR PROGRESSING AND EXPANDING CLINICAL DEVELOPMENT OF BI-1206, Source text for Eikon: Further company coverage: (Reporting By Johan Ahlander)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below